Johannesson M, Johansson P O, Jönsson B
Centre for Health Economics, Stockholm School of Economics, Sweden.
Pharmacoeconomics. 1992 May;1(5):325-37. doi: 10.2165/00019053-199201050-00004.
The aim of this paper is to review the use of the contingent valuation (CV) method in economic evaluation of drug therapy. With the CV method, willingness to pay for a project 'treatment' is measured with survey methods, which makes it possible to carry out traditional cost-benefit analysis. The CV method has been developed in environmental economics and is now the most commonly used method of measuring environmental benefits. Due to the limitations of existing methods, empirical applications are starting to appear in the health field as well. From the empirical applications with respect to drug treatment it is evident that it is possible to achieve acceptable response rates. The methodological problems encountered when measuring willingness to pay with survey methods are similar to the problems encountered when measuring utility and quality of life in cost-utility analysis. It is concluded that further studies with the CV method are necessary to further explore questions concerning the reliability and validity of the method in this field.
本文旨在综述条件价值评估（CV）方法在药物治疗经济评估中的应用。采用CV方法，通过调查方法衡量为项目“治疗”支付的意愿，这使得进行传统的成本效益分析成为可能。CV方法是在环境经济学中发展起来的，现在是衡量环境效益最常用的方法。由于现有方法的局限性，实证应用也开始出现在健康领域。从药物治疗的实证应用来看，显然有可能获得可接受的回应率。用调查方法衡量支付意愿时遇到的方法学问题与成本效用分析中衡量效用和生活质量时遇到的问题相似。得出的结论是，有必要进一步开展使用CV方法的研究，以进一步探讨该方法在该领域的可靠性和有效性问题。
